Comparative Pharmacology
Head-to-head clinical analysis: DEXTROSE 5 SODIUM CHLORIDE 0 33 AND POTASSIUM CHLORIDE 0 30 IN PLASTIC CONTAINER versus MAGNESIUM SULFATE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DEXTROSE 5 SODIUM CHLORIDE 0 33 AND POTASSIUM CHLORIDE 0 30 IN PLASTIC CONTAINER versus MAGNESIUM SULFATE.
DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 0.30% IN PLASTIC CONTAINER vs MAGNESIUM SULFATE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dextrose provides a source of calories and serves as a metabolic substrate; sodium chloride and potassium chloride replace electrolytes and maintain acid-base balance and osmotic pressure.
Magnesium sulfate acts as a physiological calcium channel blocker. It inhibits calcium influx into presynaptic nerve terminals, reducing acetylcholine release at the neuromuscular junction and decreasing muscle contraction. It also antagonizes NMDA receptors and stabilizes neuronal membranes.
Intravenous infusion; dose determined by fluid, electrolyte, and caloric requirements. Typical adult maintenance: 100-125 mL/hour; potassium not to exceed 10 mEq/hour or 200 mEq/day.
IV: Loading dose 4-6 g over 20-30 minutes, followed by maintenance infusion 1-2 g/hour for seizure prophylaxis in severe preeclampsia/eclampsia. IM: 4-8 g deep IM initially, then 4 g every 4 hours as needed.
None Documented
None Documented
Dextrose: not applicable (endogenous substance, rapidly cleared from blood; half-life of infused glucose is ~15-20 min due to cellular uptake and metabolism). Potassium: not applicable as a drug; serum potassium half-life depends on redistribution and renal function (typically ~8-12 h for a load). Sodium: no defined half-life; renal regulation maintains homeostasis.
Terminal elimination half-life approximately 4-6 hours in patients with normal renal function; prolonged to 12-24 hours or more in renal impairment, necessitating dose adjustment
Dextrose: metabolized to CO2 and water; negligible renal excretion. Sodium and potassium: primarily renal excretion (90-95% of filtered load reabsorbed; excretion adjusts to intake and balance). Chloride: renal excretion, passively follows sodium. No biliary or fecal elimination of significance.
Primarily renal (90-95% as unchanged drug); minor biliary/fecal (<5%)
Category A/B
Category C
Electrolyte
Electrolyte